Researchers suggest that tailoring interventions to symptom clusters and chemotherapy course may be best management strategy.
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that our partner, Akeso, Inc. ("Akeso, ...
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.
Cancer therapies save lives but often cause neurologic damage, so we must recognize the full scope of neurotoxicity, from ...
A new study reveals that chemotherapy-induced nerve pain arises from a stress response in immune cells that triggers inflammation and neurotoxicity.
Chemotherapy may soon take a backseat. Experts say targeted therapies—drugs that attack cancer at the genetic level—are ...
The most common cholesterol drug around might help protect cancer patients from "chemo brain." Statins appeared to protect ...
The influential oncology guidelines body revised guidelines with a nod to the FDA's explicit recommendation for testing in Xeloda's label.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback